MEDSTUDY.COM
1|Page Grade A+
ADEPT Test / CSAM Questions and
Answers (100% Pass)
A 50 year old male presents to a primary care clinic with his wife after a
completion of three day inpatient admission for treatment of alcohol
withdrawal disorder. He states that he felt very depressed prior to his
admission and he still has some depression and insomnia symptoms, but that
M
he is feeling better now. Which of the following is true regarding the treatment
of patients with co-occurring depression and alcohol use disorder?
ED
Wait for 30 days of abstinence from alcohol before evaluating for treatment of
ST
depression
U
Treatment of depression with concurrent alcohol use disorder have no benefit
D
Y
Patient is feeling better, so no need for evaluation of depression
Depression was part of alcohol withdrawal symptoms, need to continue to
treatwithdrawal symptoms
,MEDSTUDY.COM
Grade A+
Evaluate for depression at admission to detoxification, as well as at the time
of discharge,regardless of days of sobriety days
Evaluate for depression at admission to detoxification, as well as at the
time of discharge, regardless of days of sobriety days
Evidence has been limited on the use of antidepressant medications in
patients with co-occuring depression and alcohol use disorder (AUD).
M
However, meta-analysis study has shown that antidepressants
ED
outperformed placebo in the treatment of depression in patients with
AUD (Iovineo). Another study also showed that among patients with
depression and AUD, those who were not given antidepressant
ST
medication at the time of discharge, 100% resumed alcohol use in 4
months (Greenfield). Another study showed that medication treatment
U
for depression with AUD has significant benefit (Nuens) * Iovineo,
Antidepressants for major depressive disorder and dysthymic disorder in
D
patients with comorbid AUD:
Y
A first time user of oxycodone reports a sudden rush of euphoria and energy.
Which of the following neurological pathways is primarily responsible for this
effect?
Dorsal raphe nucleus projections to nucleus accumbens
Master01 | October, 2024/2025 | Latest update
,MEDSTUDY.COM
1|Page Grade A+
Nucleus accumbens projections to ventral tegmental area
Ventral tegmental area projections to dorsal raphe nucleus
Ventral tegmental area projections to nucleus accumbens
M
Ventral tegmental area projections to nucleus accumbens
ED
The positive reinforcing effects of substances and pleasurable
ST
behaviors due to dopaminergic projections from the ventral tegmental
area (VTA) to the nucleus accumbens (NAcc) represents the neural
mechanism most consistently implicated in the development of
U
addiction, especially in early stages. The NAcc along with the olfactory
D
tubule are located in the ventral striatum. The dorsal raphe nucleus is a
midbrain cluster of serotonergic neurons, which may be relevant for the
Y
effects of certain substances such as hallucinogens and MDMA, but is
not as universally implicated in substance and behavioral positive
reinforcement.
Master01 | October, 2024/2025 | Latest update
, MEDSTUDY.COM
1|Page Grade A+
1. As part of a research study, volunteers with severe opioid use disorder
receive monetary vouchers for providing opioid-negative urine samples.
Which of the following best describes this behavioral treatment strategy?
twelve-step facilitation
contingency management
cognitive behavioral therapy
M
community reinforcement
ED
motivational enhancement
contingency management
ST
2. A 28-year-old male is brought to the ED by his roommate for agitation after
a prolonged cocaine binge. His BP is 160/90 and HR is 125. The most
U
appropriate medication would be:
D
IV haloperidol
Y
IV lorazepam
IV labetalol
IV chlorpromazine
sublingual clonidine
IV lorazepam
Master01 | October, 2024/2025 | Latest update
1|Page Grade A+
ADEPT Test / CSAM Questions and
Answers (100% Pass)
A 50 year old male presents to a primary care clinic with his wife after a
completion of three day inpatient admission for treatment of alcohol
withdrawal disorder. He states that he felt very depressed prior to his
admission and he still has some depression and insomnia symptoms, but that
M
he is feeling better now. Which of the following is true regarding the treatment
of patients with co-occurring depression and alcohol use disorder?
ED
Wait for 30 days of abstinence from alcohol before evaluating for treatment of
ST
depression
U
Treatment of depression with concurrent alcohol use disorder have no benefit
D
Y
Patient is feeling better, so no need for evaluation of depression
Depression was part of alcohol withdrawal symptoms, need to continue to
treatwithdrawal symptoms
,MEDSTUDY.COM
Grade A+
Evaluate for depression at admission to detoxification, as well as at the time
of discharge,regardless of days of sobriety days
Evaluate for depression at admission to detoxification, as well as at the
time of discharge, regardless of days of sobriety days
Evidence has been limited on the use of antidepressant medications in
patients with co-occuring depression and alcohol use disorder (AUD).
M
However, meta-analysis study has shown that antidepressants
ED
outperformed placebo in the treatment of depression in patients with
AUD (Iovineo). Another study also showed that among patients with
depression and AUD, those who were not given antidepressant
ST
medication at the time of discharge, 100% resumed alcohol use in 4
months (Greenfield). Another study showed that medication treatment
U
for depression with AUD has significant benefit (Nuens) * Iovineo,
Antidepressants for major depressive disorder and dysthymic disorder in
D
patients with comorbid AUD:
Y
A first time user of oxycodone reports a sudden rush of euphoria and energy.
Which of the following neurological pathways is primarily responsible for this
effect?
Dorsal raphe nucleus projections to nucleus accumbens
Master01 | October, 2024/2025 | Latest update
,MEDSTUDY.COM
1|Page Grade A+
Nucleus accumbens projections to ventral tegmental area
Ventral tegmental area projections to dorsal raphe nucleus
Ventral tegmental area projections to nucleus accumbens
M
Ventral tegmental area projections to nucleus accumbens
ED
The positive reinforcing effects of substances and pleasurable
ST
behaviors due to dopaminergic projections from the ventral tegmental
area (VTA) to the nucleus accumbens (NAcc) represents the neural
mechanism most consistently implicated in the development of
U
addiction, especially in early stages. The NAcc along with the olfactory
D
tubule are located in the ventral striatum. The dorsal raphe nucleus is a
midbrain cluster of serotonergic neurons, which may be relevant for the
Y
effects of certain substances such as hallucinogens and MDMA, but is
not as universally implicated in substance and behavioral positive
reinforcement.
Master01 | October, 2024/2025 | Latest update
, MEDSTUDY.COM
1|Page Grade A+
1. As part of a research study, volunteers with severe opioid use disorder
receive monetary vouchers for providing opioid-negative urine samples.
Which of the following best describes this behavioral treatment strategy?
twelve-step facilitation
contingency management
cognitive behavioral therapy
M
community reinforcement
ED
motivational enhancement
contingency management
ST
2. A 28-year-old male is brought to the ED by his roommate for agitation after
a prolonged cocaine binge. His BP is 160/90 and HR is 125. The most
U
appropriate medication would be:
D
IV haloperidol
Y
IV lorazepam
IV labetalol
IV chlorpromazine
sublingual clonidine
IV lorazepam
Master01 | October, 2024/2025 | Latest update
